Segall Bryant & Hamill’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,798
Closed -$391K 725
2023
Q2
$391K Hold
3,798
﹤0.01% 599
2023
Q1
$414K Sell
3,798
-126,746
-97% -$13.8M ﹤0.01% 597
2022
Q4
$14.9M Sell
130,544
-51,149
-28% -$5.82M 0.17% 170
2022
Q3
$11.2M Buy
181,693
+44,072
+32% +$2.73M 0.13% 187
2022
Q2
$11M Sell
137,621
-25,094
-15% -$2M 0.12% 185
2022
Q1
$17.1M Buy
162,715
+30,834
+23% +$3.24M 0.16% 152
2021
Q4
$14.2M Sell
131,881
-4,024
-3% -$434K 0.13% 175
2021
Q3
$14.9M Sell
135,905
-15,811
-10% -$1.73M 0.14% 164
2021
Q2
$14.2M Buy
151,716
+15,165
+11% +$1.42M 0.14% 172
2021
Q1
$12.6M Sell
136,551
-32,763
-19% -$3.02M 0.12% 189
2020
Q4
$12.4M Buy
169,314
+9,136
+6% +$668K 0.14% 169
2020
Q3
$12.4M Buy
160,178
+37,432
+30% +$2.91M 0.17% 138
2020
Q2
$6.82M Sell
122,746
-20,904
-15% -$1.16M 0.11% 182
2020
Q1
$4.26M Buy
143,650
+13,296
+10% +$394K 0.09% 217
2019
Q4
$4.72M Sell
130,354
-6,347
-5% -$230K 0.07% 259
2019
Q3
$3.72M Sell
136,701
-22,169
-14% -$604K 0.06% 315
2019
Q2
$3.82M Buy
158,870
+7,389
+5% +$178K 0.06% 313
2019
Q1
$4M Sell
151,481
-138,972
-48% -$3.67M 0.06% 305
2018
Q4
$5.68M Sell
290,453
-173,995
-37% -$3.4M 0.1% 244
2018
Q3
$9.09M Sell
464,448
-167,885
-27% -$3.29M 0.13% 205
2018
Q2
$10.5M Sell
632,333
-50,777
-7% -$841K 0.16% 176
2018
Q1
$9.7M Sell
683,110
-41,892
-6% -$595K 0.22% 114
2017
Q4
$10.6M Buy
725,002
+81,074
+13% +$1.18M 0.23% 114
2017
Q3
$8.17M Buy
643,928
+52,454
+9% +$665K 0.19% 129
2017
Q2
$7.02M Buy
+591,474
New +$7.02M 0.17% 138